man zu fei de you hua zhi liao yu ge xin yan tao hui zai shang hai cheng gong zhao kai

..............page:1196

The new intravenous P2Y₁₂ receptor antagonist cangrelor
LIU Mei;Department of Geriatrics;Peking University First Hospital;

..............page:1201-1205

Expert investigation to establish drug patent linkage system in China
LIU Jing-jing;WU Zhi-ang;Shenyang Pharmaceutical University;

..............page:1206-1211

Future development of the generics business from the point view of intellectual property
JI Yuan-yuan;ZHOU Dong-ming;Postdoctoral Programme of China Center for Industrial Security Research;Beijing Jiaotong University;Zhongmaiwandong Pharmaceutical Technology Co.;Ltd.;

..............page:1212-1215

Economic evaluation of dabigatran,rivaroxaban and warfarin in preventing stroke in patients with atrial fibrillation
CHEN Yong-fa;HAN Hong-na;School of International Pharmaceutical Business;China Pharmaceutical University;

..............page:1216-1224

Advances in the development of Axl inhibitors
WU Yan-jun;SUN Ming-ming;XI Ning;Department of New drug;Sunshine Lake Pharmaceutical Co.;Ltd.;Calitor Sciences LLC;

..............page:1225-1235

Progress in research on the mitochondrial mechanism of ischemica stroke and effective components of TCM
CHEN Hong;WU Jun-jie;XUE Qiang;XU Xiao-yu;Department of Pharmacy;Southwest Hospital;Third Military Medical University;College of Pharmaceutical Sciences & Chinese Medicine;Southwest University;

..............page:1236-1240

Factors influencing matrix effects of sabarubicin and its major metabolite in human plasma during liquid chromatography-tandem mass spectrometry analysis
ZHANG Yan;SONG Yuan-yuan;SONG Wen-ya;SHI Yuan-kai;HAN Xiao-hong;Department of Medical Oncology;Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs;National Cancer Center/Cancer Hospital;Chinese Academy of Medical Sciences and Peking Union Medical College;Clinical Laboratory of Medicine;National Cancer Center/Cancer Hospital;Chinese Academy of Medical Sciences and Peking Union Medical College;

..............page:1241-1247

Application of diuretics in the treatment of resistant hypertension
WANG Cong-shui;YU Zhen-qiu;KUANG Ze-min;University of South China;Department of Hypertension;Beijing Anzhen Hospital Affiliated to Capital Medical University;

..............page:1248-1252

Effect of estrogen and its receptor in fat metabolism
HU Wen-min;ZHANG Ling;LI Lin-zi;WANG Yin;Zhejiang Academy of Medical Sciences;

..............page:1253-1257

Advance in research of the safer NSAIDs
Lü Tian;YE Hai;ZHANG Can;Center of Drug Discovery;China Pharmaceutical University;Nanjing Heron Pharmaceutical Science and Technology Co.;Ltd.;

..............page:1258-1265

Effect of SLCO1B1 gene polymorphism on lipid-lowering efficacy of atorvastatin
FU Qiang;LI Yan-peng;The Third Affiliated Hospital;Zhengzhou University;The First Affiliated Hospital;Zhengzhou University;

..............page:1266-1270

Effect of simethicone combined with compound polyethylene glycol electrolyte powder on bowel preparation before capsule endoscopy
YU Lan;CUI Li-hong;FU Shan-feng;PU Jiang;LIU Chao-qun;WANG Xiao-hui;WANG Shao-xin;Department of Gastroenterology;Chinese PLA NAVY General Hospital;

..............page:1271-1274

Preparation,characterization and photothermal effect of niosomes assembled with carbocyanine dyes
LIU Di;YANG Hong;Lü Xiao-yan;WANG Xue;XIE Meng-yu;LUO Geng;FU Pei;ZHAO Cheng-long;YAO Feng-feng;XU Tao;College of Pharmaceutical Sciences;Soochow University;

..............page:1275-1280

Effect of “Ying-Wei-Tong-Luo prescription”on the vasa vasorum angiogenesis in early atherosclerosis
YIN Yu-jie;MA Liu-yi;JIA Zhen-hua;ZHANG Jun-fang;WANG Hong-tao;SHAN Xing-ge;LIU Huan;Hebei Medical University;Department of Cardiology;Yiling Medical Institute of Hebei Province;Yiling Hospital of Hebei Medical University;

..............page:1281-1285

3D-QSAR and molecular docking studies on 6-alkenylamides substituted of 4-anilinothieno [2,3-d]pyrimidines as inhibitors of EGFR tyrosine kinase
WANG Bi-wu;WEN Xiao-rong;SHU Mao;HU Yong;LIN Zhi-hua;Chongqing University of Technology;College of Pharmaceutical and Biological Engineering;Chongqing University;School of Chemistry and Chemical Engineering;

..............page:1286-1292

Inhibitory effect of BP0018 on hepatitis B virus in vivo
TIAN Xin;LI Zhuang;LIU Mei;China-Tai Tianqing Pharmaceutical Group Co.;Ltd.;Institute of Medicinal Biotechnology;Chinese Academy of Medical Sciences;

..............page:1293-1297

Effect of L-carnitine combined with trimetazidine hydrochloride on anti-hypoxic ability in rats and the mechanism
XIE Shen-wei;XU Gang;YUAN Zhi-bing;GAO Yu-qi;GU Shu-hua;XIE He-bing;Institute of Medicine and Hygienic Equipment for High Altitude Region;College of High Altitude Military Medicine;Third Military Medical University;Key Laboratory of High Altitude Medicine;Ministry of Education;The Key Laboratory of High Altitude Medicine;PLA;Changzhou SIMM Pharmaceutical Research and Development Center Co.;Ltd.;

..............page:1298-1303

Synthesis of Trolline
SUN Qi;ZHANG Ting-jian;LIANG Jing-wei;MENG Fan-hao;Department of Medicinal Chemistry;School of Pharmacy;China Medical University;

..............page:1304-1306

Bitterness intensity prediction of bitter compounds of traditional Chinese medicine based on an electronic tongue
LI Xue-lin;GUI Xin-jing;LIU Rui-xin;GAO Xiao-jie;MENG Xiang-le;CHEN Peng-ju;KANG Bing-ya;ZHANG Lu;SHI Jun-han;Henan University of Traditonal Chinese Medicine;Department of Pharmacy;The First Affiliated Hospital of Henan University of Traditonal Chinese Medicine;

..............page:1307-1314

Analysis on the use of traditional Chinese medicine injections for heat-clearing and detoxifying in medical institutions from 2008 to 2014
ZHAO Liang;HAN Sheng;SHI Lu-wen;LI Wen-sheng;Peking University School of Pharmaceutical Sciences;International Research Center of Medicinal Administration;

..............page:1315-1320